Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?

MLA

Yoon GJ, et al. “Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies Are Clinicians Responding Optimally?” Journal of the American College of Cardiology (JACC), vol. 56, no. 20, Nov. 2010, pp. 1644–50. EBSCOhost, https://doi.org/10.1016/j.jacc.2010.07.023.

APA

Yoon GJ, Telli ML, Kao DP, Matsuda KY, Carlson RW, Witteles RM, Yoon, G. J., Telli, M. L., Kao, D. P., Matsuda, K. Y., Carlson, R. W., & Witteles, R. M. (2010). Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally? Journal of the American College of Cardiology (JACC), 56(20), 1644–1650. https://doi.org/10.1016/j.jacc.2010.07.023

Chicago

Yoon GJ, Telli ML, Kao DP, Matsuda KY, Carlson RW, Witteles RM, Geoffrey J Yoon, et al. 2010. “Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies Are Clinicians Responding Optimally?” Journal of the American College of Cardiology (JACC) 56 (20): 1644–50. doi:10.1016/j.jacc.2010.07.023.